In clinical research, roughly a third of the weight lost on GLP-1 medications was lean mass, not fat. Here are the three habits women are building so the weight that leaves is the weight they actually wanted gone.
See the Complete Toolkitor read the three habits first
Educational only. Medication decisions belong with a licensed healthcare provider.
Illustrative, based on ranges discussed in published research.
When appetite shrinks to a few bites per meal, protein is usually the first thing that quietly disappears. A protein floor is a planned minimum, decided in advance, eaten first on the plate.
In a calorie deficit, the body tends to keep what it uses. Two short strength sessions a week are the signal that says: keep the muscle, burn the fat.
The scale cannot tell fat from muscle. Simple weekly measurements, strength benchmarks, and energy scores can.
These three habits are the core of the GLP-1 Companion Toolkit, organized into one practical system.
GLP-1 medications can quiet appetite so effectively that eating becomes an afterthought. When overall food intake drops fast, protein often drops with it, and rapid weight loss without enough protein and strength training can cost lean mass along with fat.
That is not a discipline problem. It is a fueling and training problem, and it is addressable. The goal is never to eat less than the medication already makes you eat. It is to make what you do eat, and two short sessions a week, protect the part of you that keeps your metabolism, strength, and shape.
In a body composition sub-study of the STEP 1 trial, a meaningful share of the weight lost on semaglutide was lean mass rather than fat, with published analyses discussing figures around one third. And in extension studies, many participants regained much of the lost weight within a year of stopping treatment. The muscle and habits built during treatment are what remain afterward.
THE LEAN LOSS GAP
Researchers call it simple biology. We call it the Lean Loss Gap: the medication creates the deficit and removes the appetite that used to deliver your protein. Closing that gap is the part that is yours, and it is very closeable.
Lean mass supports strength, joints, energy, and resting metabolism.
Both are repeatedly discussed in the clinical literature around GLP-1 treatment. The details should fit your body and your clinician's guidance.
Medication decisions and concerning symptoms belong with a licensed healthcare provider.
A complete digital system built to help women protect muscle and energy during GLP-1 treatment: a 90-day companion guide, a muscle protection training plan, a protein-first meal system for small appetites, tracking that sees more than the scale, and preparation for clearer conversations with your care team.
This educational toolkit does not advise you to start, stop, or change medication. Make medication decisions with your licensed healthcare provider.
Research citations are provided for informational context only. They do not constitute endorsement of this product by the cited authors or institutions.